What are the best treatments for Atrial Septal Defects?

Treatments for Atrial Septal Defects depend on the size and location of the hole, with options ranging from regular clinical monitoring to minimally invasive catheter-based closures or open-heart surgery. While small Atrial Septal Defects may close spontaneously in childhood, larger defects typically require intervention to prevent long-term complications like pulmonary hypertension or heart failure.

How are Atrial Septal Defects treated medically?

For many patients, Atrial Septal Defects do not require immediate surgery if the defect is small and asymptomatic. When symptoms exist, medications are used to manage complications rather than to close the defect itself. Commonly prescribed medications include diuretics (e.g., furosemide) to reduce fluid buildup, antiarrhythmics (e.g., digoxin or beta-blockers) to control irregular heart rhythms, and occasionally anticoagulants to lower the risk of blood clots.

What surgical and procedural options exist for Atrial Septal Defects?

When intervention is necessary, the goal is to prevent permanent damage to the heart and lungs. The following approaches are standard practice for treating Atrial Septal Defects:

• Transcatheter Closure: A minimally invasive procedure where a mesh device (such as the Amplatzer septal occluder) is guided through a vein to the heart to plug the hole.


• Surgical Repair: Used for larger or complex Atrial Septal Defects, this involves open-heart surgery to stitch the hole closed or place a patch over the defect.


• Ongoing Monitoring: Regular echocardiograms are essential to track the size of the defect and cardiac function over time.

Which specialists should be on the care team?

Management of Atrial Septal Defects requires a multidisciplinary team to ensure optimal outcomes. A typical care team includes a pediatric or adult congenital cardiologist, a cardiothoracic surgeon, an imaging specialist (echocardiographer), and a nurse practitioner specializing in congenital heart disease. Our DiseaseMaps.org community of 47 members highlights the value of connecting with others who have navigated these specific multidisciplinary care pathways.

Are there emerging treatments or clinical trials?

Research into Atrial Septal Defects continues to focus on improving the biocompatibility of closure devices and refining robotic-assisted surgical techniques. Clinical trials are currently exploring long-term outcomes of newer generation occluder devices to minimize the risk of late-term complications.

Next steps

• Schedule a consultation with an adult or pediatric congenital cardiologist.


• Request a comprehensive transthoracic or transesophageal echocardiogram.


• Join the DiseaseMaps.org community to share experiences with others living with Atrial Septal Defects.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice; please consult your cardiology team for a personalized treatment plan.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• American Heart Association (AHA) - Congenital Heart Defects


• Orphanet: Portal for rare diseases and orphan drugs


• Adult Congenital Heart Association (ACHA)